Committed to helping you navigate life with PAH
The PAH Initiative is dedicated to advancing patient care in pulmonary arterial hypertension.
This initiative reflects United Therapeutics’ commitment to providing knowledge and inspiration based on science and research in PAH today. Here, you will open a doorway that helps you better understand what’s happening, why it’s happening, and what you and your healthcare provider can do about it.
Our hope is that you find the support and treatment you need–when you need it–so you and your healthcare provider can make informed decisions that help you throughout your PAH journey.
Join the PAH Initiative
Sign up now to stay informed with updates from the PAH Initiative and United Therapeutics. When you do, you can receive a free exercise tracker and phone-carrying bag.
What’s happening in
your heart and
lungs when you
have PAH?
When you have pulmonary arterial hypertension (PAH), the blood vessels in your lungs become narrower. This causes your heart to work harder to pump blood to your lungs.
What is “risk status” and why is it so important for treating PAH?
Risk status helps your healthcare provider understand your disease today and predict the probability of your survival over the next 3 to 5 years.
How is PAH
treated and
what are your
options?
There are 3 pathways that are critical to treating PAH. Each PAH treatment pathway helps to balance natural substances in your blood vessels.
|
|
